Arrhythmia as a Possible Complication of Mycophenolate Mofetil in Systemic Sclerosis: A Case Report
Open Access
- 1 January 2025
- journal article
- case report
- Published by Wiley in Case Reports in Medicine
- Vol. 2025 (1) , 8858671
Abstract
A 55‐year‐old male patient with diffuse cutaneous systemic sclerosis (dcSSC) since 2018 presented with a history of arrhythmia. He had been stable for 5 years with pantoprazole, diltiazem, and mycophenolate mofetil (MMF); vitamin E; and vitamin D until he developed arrhythmia. Different evaluations revealed left bundle branch block, wall motion abnormality, mildly reduced systolic function, diffused interstitial fibrosis, and lesions in the left circumflex artery (LCX) and left anterior descending artery (LAD) and stenosis in LCX, without significant improvement following percutaneous coronary intervention for LCX stenosis. Holter monitoring demonstrated persistent ventricular premature beats and couplets. Arrhythmia was not responsive to bisoprolol therapy, and it was not feasible to perform cardiac ablation. Suspecting MMF–induced arrhythmia, MMF was discontinued, which led to a reduction in arrhythmia and symptom improvement after 9 months. This case report emphasized a possible heart‐related complication of MMF, which healthcare providers should consider when prescribing medication to patients.Keywords
This publication has 11 references indexed in Scilit:
- Arrhythmias and Conduction Disturbances in Patients with Systemic Sclerosis—A Systematic Literature ReviewInternational Journal of Molecular Sciences, 2022
- Cardiovascular effects of immunosuppression agentsFrontiers in Cardiovascular Medicine, 2022
- Emerging treatments for scleroderma/systemic sclerosisFaculty Reviews, 2021
- Cardiac manifestations in systemic sclerosisWorld Journal of Cardiology, 2014
- Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesRheumatology, 2011
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Patient Outcomes in Two Steroid-Free Regimens Using Tacrolimus Monotherapy After Daclizumab Induction and Tacrolimus With Mycophenolate Mofetil in Liver TransplantationTransplantation, 2008
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJournal of Clinical Investigation, 2007
- Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2005
- Immunosuppressants: Cellular and molecular mechanisms of actionAmerican Journal of Kidney Diseases, 1996